| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Coherus Oncology, Inc. (CHRS) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. CHRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 30.0K | $44.4K | - | |
| CFO | 15.0K | $22.2K | - | |
| CEO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2016 | Lanfear Dennis M | President And CEO | Sell | 4,060 | $31.75 | $128,909.81 | -0.2% | |
| Sep 16, 2016 | Lanfear Dennis M | President And CEO | Sell | 2,900 | $31.79 | $92,199.12 | -0.2% | |
| Sep 1, 2016 | Herman Alan C. | Chief Scientific Officer | Sell | 16,999 | $29.99 | $509,715.02 | -9.1% | |
| Aug 8, 2016 | Fmr LLC72 | See Remark 1 | Sell | 100,000 | $29.86 | $2,986,216.27 | -3.7% | |
| Aug 8, 2016 | Watler Peter K. | Chief Technical Officer | Sale+OE | 55,621 | $30.00 | $1,668,664.75 | -100% | |
| Aug 5, 2016 | Fmr LLC72 | 10% Owner, See Remark 1 | Sell | 48,600 | $28.48 | $1,383,988.00 | -2.0% | |
| Aug 1, 2016 | Herman Alan C. | Chief Scientific Officer | Sell | 11,333 | $25.54 | $289,433.49 | -5.7% | |
| Jul 21, 2016 | Watler Peter K. | Chief Technical Officer | Sale+OE | 3,991 | $26.13 | $104,271.81 | -85.1% | |
| Jul 20, 2016 | Watler Peter K. | Chief Technical Officer | Sale+OE | 73,741 | $25.02 | $1,844,735.00 | -100% | |
| Jul 11, 2016 | Watler Peter K. | Chief Technical Officer | Sale+OE | 43,495 | $20.02 | $870,930.83 | -100% |